thiophenes has been researched along with Bile Duct Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boonmars, T; Chusorn, P; Jongthawin, J; Khuntikeo, N; Loilome, W; Namwat, N; Puapairoj, A; Tassaneeyakul, W; Techasen, A; Thanan, R; Yongvanit, P | 1 |
| Hematulin, A; Sagan, D; Sawanyawisuth, K; Seubwai, W; Wongkham, S | 1 |
2 other study(ies) available for thiophenes and Bile Duct Cancer
| Article | Year |
|---|---|
PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.
Topics: 4-Butyrolactone; Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Cyclooxygenase 2; Dinoprostone; Female; Humans; Intramolecular Oxidoreductases; Male; Middle Aged; Prostaglandin-E Synthases; Signal Transduction; Thiophenes | 2014 |
Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Dose-Response Relationship, Radiation; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Radiation Tolerance; Thiophenes; Tumor Suppressor Protein p53; Urea | 2014 |